Stay updated on SPI-1005 in Meniere's Disease Clinical Trial
Sign up to get notified when there's something new on the SPI-1005 in Meniere's Disease Clinical Trial page.

Latest updates to the SPI-1005 in Meniere's Disease Clinical Trial page
- Check3 days agoChange DetectedThe footer’s ClinicalTrials.gov revision marker was updated from v3.7.0 to v3.7.1 while the page remained a 403 Forbidden error.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content, indicating that access to the researcher view is blocked; a standard navigation/footer remains visible.SummaryDifference18%

- Check45 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing Revision: v3.6.5. This reflects a recent update to the ClinicalTrials.gov interface rather than any changes to study data.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page now shows Revision: v3.6.5 instead of v3.6.4, indicating a minor site update. This does not alter trial information or how users interact with the page.SummaryDifference0.1%

- Check81 days agoChange DetectedNew safety and efficacy endpoints are added and described: the Number of Participants With Treatment-Emergent Adverse Events (TEAEs) within 84 days, and a co-primary efficacy endpoint based on WIN Score Improvement from Baseline of ≥4 words with a detailed description of the Words-in-Noise (WIN) test. The previous adverse events and WIN-related endpoints are removed or revised accordingly.SummaryDifference0.6%

- Check102 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3 in the page footer, indicating a minor update to the interface. The core study data and options appear unchanged.SummaryDifference0.1%

Stay in the know with updates to SPI-1005 in Meniere's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPI-1005 in Meniere's Disease Clinical Trial page.